Erica Joyner – Page 23 – In The States

Ohio

Medicaid (ODM)announced that Myers and Stauffer have begun sending acquisition cost surveys to pharmacies to help them determine Ohio Average Acquisition Cost (OAAC). ODM intends to use OAAC as part of the “lower of” calculation for ingredient cost reimbursement, to include NADAC and Usual and Customary, when they implement “The Next Generation of Managed Care.” Completed surveys are due April 30 and can be submitted by email, U.S. Post, or fax, as noted below, though electronic submission is preferred.

Email OHSurveys@mslc.com. The email subject link should read: “Ohio Pharmacy Survey.”
Mail Myers and Stauffer LC, Attn.: Ohio Pharmacy Survey 800 East 96th Street, Suite 200 Indianapolis, IN 46240.
Fax 317-566-3203. On the cover page, please include “ATTN – Ohio Pharmacy Survey.”

To learn more about the Next Generation of Medicaid managed care, visit Ohio Medicaid Single Pharmacy Benefit Manager (SPBM) | Ohio Medicaid Managed Care or email ODM at MedicaidSPBM@medicaid.ohio.gov.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2022-04-08T12:06:29-04:00April 8, 2022|Ohio|

Oregon

The Oregon Health Authority is implementing changes to the Prior Authorization Guide and the Preferred Drug List, including select over-the-counter product classes, to ensure the safe and appropriate use of cost-effective prescription drug for Oregon Health Plan’s fee-for-service recipients. his is a temporary rule effective April 1, 2022, through June 25, 2022.

Also in Oregon, the Oregon Health Authority issued a Notice of Proposed Rulemaking, making permanent changes to the Prior Authorization Guide and the Preferred Drug List, including select over-the-counter product classes, currently in effect as a temporary rule effective April 1, 2022, through June 25, 2022. Comments are due 5:00 p.m. on May 21.

Finally in Oregon, the Board of Pharmacy posted a REVISED agenda and meeting materials for the April 13-15 meeting.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Erica Joyner2022-04-08T12:02:35-04:00April 8, 2022|Oregon|

Tennessee

Please see the updates to the PDL, Clinical Criteria, and Interim Criteria below for April 2022. These changes went into effect on April 1^st.

BaG additions: Combigan
Added to preferred: naloxone, Valtoco, glycopyrrolate solution, Myfembree
Added to non-preferred: Dartisla ODT, Eprontia, Xarelto suspension, Xenleta, Brexafemme, nitazoxanide, Elepsia XR, Azstarys, adapalene/benzoyl peroxide, carglumic acid, Zokinvy, Palforzia, Lumakras, Tepmetko, Qinlock, bimonidine/timolol, Bronchitol
Added to interim: Recorlev, Tarpeyo, Livmarli, Trudhesa, Tyrvaya, Skytrofa, Besremi, Tavneos, Adbry, Livtencity
Modified criteria/quantity limits for Adderall, Adderall XR, Adefovir, Adhansia XR, Adzenys ER solution, Adzenys XR ODT, amphetamine ER suspension, Ancobon, Arikayce, Baraclude solution, clonidine ER, Cotempla XR ODT, Cresemba, Daytrana, Desoxyn, Dexedrine spansule, dexmethylphenidate XR, dextroamphetamine soln, Dificid tablet and suspension, doxycycline hyclate 20mg, Dyanavel XR, Evekeo tab & ODT, flucytosine tablets, Focalin, Fuzeon, Hepsera, Intuniv, Isentress HD, itraconazole, Jornay PM, ketoconazole, linezolid suspension, Lumakras, methamphetamine, Methylin solution, methylphenidate chewable, methylphenidate ER, methylphenidate SA OSM, methylphenidate XR ODT, Mycobutin, Mydayis ER, Nuzyra, Oravig, Pegasys syringes, Pegasys vials, Qelbree, Qinlock, Quillichew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Sporanox, terbinafine tablets, Tybost, Vemlidy, Xenleta, Zenzedi, Zyvox suspension, Zyvox tablets.

Additionally, these documents can be found on the TennCare website.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Erica Joyner2022-04-08T11:57:19-04:00April 8, 2022|Tennessee|

Texas

NACDS attended the Dallas County Medical Society’s 139^th Annual Dinner and Awards ceremony at the Frontiers of Flights Museum on April 6^th honoring chain pharmacies and pharmacists from Kroger Health and Albertsons/ Randall’s/Tom Thumb for their efforts at the beginning of the pandemic providing 20,000 COVID-19 vaccines administered to physicians who are not affiliated with a major health or hospital systems and their frontline office staff. Accepting the awards for chain pharmacies were Jeff Loesch, PharmD with The Kroger Company, and Jennifer Golden, PharmD with Albertsons Companies. This successful collaborative effort eventually led to multiple other opportunities throughout the pandemic for more chain pharmacies to work directly in Collin, Dallas, Denton Grayson, and Tarrant County Health Departments to administer COVID vaccines and tests.

People in the photos:
Dr. Philip Huang, Director, Health Authority, Dallas County Health, and Human Services Department
Jon Roth, CEO, Dallas County Medical Society
Jeff Loesch, PharmD, CHC
Jill Lester, PharmD, BCPS, BCACP
Jennifer Golden, RPh.
Emad Besslay, MPharm

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Erica Joyner2022-04-08T12:01:13-04:00April 8, 2022|Texas|

Utah

On March 23, Gov. Spencer Cox (R) signed HB 80, allowing for Medicaid reimbursement for diabetes prevention services including an additional appropriation for the Department of Health and Human Services in Fiscal Year 2022-2023. Beginning July 1, 2022, Medicaid will reimburse a provider for an enrollee’s participation in the CDC’s National Diabetes Prevention Program under certain conditions.

Also in Utah, On March 24, Gov. Spencer Cox (R) also signed SB 3, that includes a block grant in the amount of $500,000 for alcohol, tobacco and other drug prevention, reduction, cessation, and control programs or for emergent disease control and prevention needs for the Department of Health’s Disease Control and Prevention.

Finally in Utah, on March 24, Gov. Cox signed SB 236, allows a therapeutic equivalent to be dispensed for needles or other supplies for treating diabetes and allows a pharmacist to dispense up to a 100-day supply of insulin with a valid prescription among its various provisions.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Erica Joyner2022-04-08T11:49:56-04:00April 8, 2022|Utah|

Wyoming

On March 7, Gov. Mark Gordon (R) signed SF 24 (Chapter Number 7), authorizing the administration of immunizations by pharmacy technicians and pharmacy interns. It also eliminates the statutory definition of “direct” supervision requirements for pharmacy technicians and pharmacy interns, leaving the “supervision” requirements to be further specified by the Board of Pharmacy.

Also in Wyoming, on March 15, Gov. Mark Gordon (R) signed SF 101 (Chapter Number 69), permitting pharmacists to prescribe an opiate antagonist in accordance with the Emergency Administration Medical Treatment Act. It also directs the Board of Pharmacy, in cooperation with the Board of Medicine, to adopt rules delineating the requirements a pharmacist must need to prescribe an epinephrine auto-injector.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Erica Joyner2022-04-08T11:49:00-04:00April 8, 2022|Wyoming|

Alabama

As Alabama Medicaid continues to monitor the COVID-19 national emergency in Alabama, Medicaid is adding procedure codes for coverage. Providers may submit claims for dates of service on or after the effective dates for each procedure code as listed here. Providers may find the reimbursement rates for the COVID-19 testing procedure codes on Medicaid’s website at www.Medicaid.Alabama.gov by selecting Fee Schedules under the Providers tab.

Also in Alabama, effective January 1, 2020, all newly registered technicians are required to complete a Board approved training program within six (6) months of the registration. Technicians with Board approved training completed, PTCB or CPhT certifications, or registered prior to January 1, 2020, will be reflected as compliant with the training requirement on the technicians’ Board of Pharmacy website profile.

To view this data:

Go to albop.com
Click Online Services
Choose “Individual Verification” from the dropdown menu
Input the technician registration number or name of the technician and enter the verification code displayed and click Search
Identify the technician and choose the Print option to view the full license details including training information for technicians.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Erica Joyner2021-12-03T09:51:45-05:00December 3, 2021|Alabama|

Alaska

The Department of Commerce, Community, and Economic Development cut the initial registration and biennial renewal fees for the prescription drug monitoring program-controlled substance prescription database to $0 effective December 23, 2021.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Erica Joyner2021-12-03T09:50:35-05:00December 3, 2021|Alaska|

Arkansas

Gov. Asa Hutchinson (R) is convening a Special Session of the Legislature on Tuesday, December 6^th to deal with income tax reform and repeal of the Insulin Rebate law (Act 1104/HB 1709).

Also in Arkansas, the Department of Health final rules amending the Prescription Drug Monitoring Program to provide for an alternate method of reporting and allow the department to request prescription copies from dispensers for evaluation go into effect on December 3, 2021.

Finally in Arkansas. The Division of Medical Services adopted a rule revising the rate methodology and reimbursement rates for covered long-acting reversible contraceptives (LARCs) that went into effect on December 1, 2021.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Erica Joyner2021-12-03T09:46:54-05:00December 3, 2021|Arkansas|

About Erica Joyner